ABREVA
NDC 0135-0300, docosanol, cream, from Haleon US Holdings LLC.
- Product NDC
- 0135-0300
- Status
- Listed
- Labeler
- Haleon US Holdings LLC
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA208754
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0135-0300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOCOSANOL100 mg/g
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0135-0300-01 | 00135030001 | 1 TUBE in 1 PACKAGE (0135-0300-01) / 2 g in 1 TUBE |
| 0135-0300-02 | 00135030002 | 2 TUBE in 1 PACKAGE (0135-0300-02) / 2 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0135-0300 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0135-0300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0135-0300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.